Content continues after advertisement

Canine Sebaceous Adenitis

Alexander Werner Resnick, VMD, DACVD, Animal Dermatology Center

Dermatology

|June 2013|Peer Reviewed

Sign in to Print/View PDF

Sebaceous adenitis (SA) is an inflammatory disorder that causes immune-mediated destruction of the sebaceous glands. The pathogenesis is likely multifactorial; however, an autosomal recessive mode of inheritance has been proposed for the standard poodle and Akita.

Related Article: Canine Scaling Disorders

Several distinct presentations are recognized, although the hallmark clinical sign is adherent crusting of hair shafts with follicular casts (ie, keratin collaring) (See Figure 1 above, Labradoodle with adherent crusts (ie, keratin collaring) on hair shafts. The long, curly hair coat has become straight and brittle). Because several diseases can appear clinically similar to SA, it can only be definitively diagnosed by biopsy.

Multiple circular lesions with fine silvery scales on the pinna of a vizsla.

Clinician's Brief

Long-coated breeds typically develop lesions first on the dorsal muzzle and temporal region. Over time, lesions can progress to the body (primarily dorsally and bilaterally symmetrical) and tail. The hair coat often becomes straighter and more brittle. In the Akita, signs can rapidly generalize, with more severe lesions of secondary pyoderma potentially causing pruritus and systemic illness that can lead to increased morbidity.

Related Article: Acute Onset of Alopecia & Erythematous Dermatitis in a Vizsla

Short-coated breeds, typified by the vizsla and dachshund, can develop discrete circular patches or plaques with alopecia and adherent fine scale (Figure 2).

Lesions primarily develop on the body, face, and pinnae (Figure 3).

Clinician's Brief
Pinna of a crossbreed dog before (A) diagnosis of SA and after (B) 6 months of therapy. There are significantly fewer adherent crusts and evident hair regrowth following treatment.

Multiple treatment options for SA are available, including a recent focus on cyclosporine A. A partly blinded, placebo-controlled study comparing cyclosporine A at 5 mg/kg PO q24h and topical therapy (ie, antiseborrheic topical therapy and frequent bathing) established that both treatment modalities were effective individually, but a synergistic effect was noted when used concurrently.1 Control of SA requires lifelong therapy.

References and Author Information

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Podcasts

Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2023 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy